Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Venezuelan opposition says Maduro government violated COVID response agreement

Published 01/22/2021, 03:54 PM
Updated 01/22/2021, 03:55 PM

CARACAS (Reuters) - Venezuela's opposition accused President Nicolas Maduro's government on Friday of unilaterally changing the destination of medication and equipment provided by the Pan American Health Organization, in a "clear violation" of an agreement to address the COVID-19 pandemic.

Last June, Venezuela's health ministry and technical advisers to the then opposition-dominated National Assembly signed an agreement to implement a COVID-19 response supported by PAHO. By October, 340,000 antigen tests and 35 test-reading machines, managed by PAHO, had arrived in the country.

The ministry and technical advisers had agreed the tests and machines would be sent to 27 hospitals, Miguel Pizarro, designated by opposition leader Juan Guaido as representative to the United Nations, said in a statement.

But the government transferred the supplies to its own network of regional laboratories and other centers that Pizarro said in his statement were "not prepared for the care of patients with COVID-19."

With the equipment in public health laboratories, Pizarro said, the government now has "absolute control" over test results and the country's COVID-19 data.

Venezuela's information ministry and spokespeople for the Washington-based PAHO did not immediately respond to a request for comment.

Only around 3,000, or about 1%, of the 3400,000 antigen tests sent to Venezuela have so far been used, Ciro Ugarte, director of health emergencies at PAHO, said on Tuesday while giving a regular weekly update on the pandemic.

Venezuelan authorities have reported 122,260 infections and 1,129 deaths from COVID-19 since the pandemic began. Experts say the real number is likely higher, due to low levels of testing.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.